Robert I. Fox

发表

Reactivation of Epstein-Barr virus in Sjögren’s syndrome

F. Howell, Robert I. Fox, Francis V. Howell, 1987, La Ricerca in clinica e in laboratorio.

Sjögren’s syndrome: current therapies remain inadequate for a common disease

R. Fox, Robert I. Fox, 2000, Expert opinion on investigational drugs.

Vth International Symposium on Sjögren’s Syndrome Clinical Aspects and Therapy

R. Fox, Robert I. Fox, 1995, Clinical rheumatology.

Synthetic peptide derived from the epstein‐barr virus encoded early diffuse antigen (ea‐d) reactive with human antibodies

R. Houghten, R. Fox, J. Vaughan, 1987 .

Cross-reacting idiotypes on cryoprecipitating rheumatoid factor

Pojen P. Chen, G. Silverman, D. Carson, 2005, Springer Seminars in Immunopathology.

Emerging treatment for Sjögren’s disease: a review of recent phase II and III trials

C. Fox, Sara S. McCoy, Robert I. Fox, 2023, Expert opinion on emerging drugs.

Criteria for diagnosis of Sjögren's syndrome.

I. Saito, R. Fox, Robert I. Fox, 1994, Rheumatic diseases clinics of North America.

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

J. Kremer, M. Weinblatt, R. Fleischmann, 1999, The New England journal of medicine.

Primary Sjogren syndrome: clinical and immunopathologic features.

R. Bone, F. Howell, R. Fox, 1984, Seminars in arthritis and rheumatism.

Mechanism of action of hydroxychloroquine as an antirheumatic drug.

R. Fox, Robert I. Fox, 1993, Seminars in arthritis and rheumatism.

Treatment of primary Sjögren's syndrome with hydroxychloroquine.

F. Howell, R. Fox, S. Fong, 1988, The American journal of medicine.

The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.

R. Beuerman, Jian-ping Gao, S. Pflugfelder, 1998, Cornea.

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

R. Jonsson, S. Pillemer, S. Bombardieri, 2002, Annals of the rheumatic diseases.

Mechanism of action for leflunomide in rheumatoid arthritis.

G. Wahl, C. Frangou, V. Strand, 1999, Clinical immunology.

Sjögren's syndrome. Proposed criteria for classification.

C. Robinson, F. Howell, R. Fox, 1986, Arthritis and rheumatism.

First international symposium on Sjögren's syndrome: suggested criteria for classification.

R. Bone, C. Robinson, F. Howell, 1986, Scandinavian journal of rheumatology. Supplement.

Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome

I. Saito, R. Fox, T. Compton, 1989, The Journal of experimental medicine.

Lysis of autologous Epstein-Barr virus-infected B cells by cytotoxic T lymphocytes of rheumatoid arthritis patients.

D. Carson, S. Slovin, R. Fox, 1982, Clinical immunology and immunopathology.

Update in Sjögren syndrome.

R. Fox, M. Stern, M. Stern, 2000, Current opinion in rheumatology.

High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren's syndrome patients

P. Pisa, R. Fox, R I Fox, 1991, The Journal of experimental medicine.

Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.

J. Abrams, Hoil Kang, R. Fox, 1994, Journal of immunology.

Epstein-Barr virus and human autoimmune diseases: possibilities and pitfalls.

R. Fox, Robert I. Fox, 1988, Journal of virological methods.

Use of muscarinic agonists in the treatment of Sjögren's syndrome.

Y. Konttinen, A. Fisher, R. Fox, 2001, Clinical immunology.

Pathogenesis and treatment of Sjögren's syndrome.

T. Maruyama, R. Fox, T. Maruyama, 1997, Current opinion in rheumatology.

Clinical features, pathogenesis, and treatment of Sjögren's syndrome.

R. Fox, Robert I. Fox, 1996, Current opinion in rheumatology.

Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.

V. Strand, N. Olsen, D. Furst, 2001, Arthritis and rheumatism.

Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome.

E. Ben-Chetrit, E. Tan, E. Ben-Chetrit, 1990, Arthritis and rheumatism.

Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca.

J. Belmont, J. B. Michelson, P. Michelson, 1984, Arthritis and rheumatism.

Potential role of Epstein-Barr virus in Sjögren's syndrome.

J. Vaughan, L. Benton, T. Chilton, 1987, Rheumatic diseases clinics of North America.

Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis.

M. Luppi, P. Pisa, R. Fox, 1992, The Journal of rheumatology. Supplement.

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

R. Jonsson, S. Pillemer, S. Bombardieri, 2002, Annals of the rheumatic diseases.

Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis.

T. C. Adamson, R. Fox, J. Vaughan, 1984, Arthritis and rheumatism.

Pathogenesis of Sjögren's syndrome.

R. Fox, Ho‐il Kang, H. Kang, 1992, Rheumatic diseases clinics of North America.

Expression of granzyme A in salivary gland biopsies from patients with primary Sjögren's syndrome.

I. Weissman, R. Fox, S. Alpert, 1994, Arthritis and rheumatism.

Monoclonal antibodies potentially useful for diagnosis of squamous cell oral carcinoma

I. Saito, F. Howell, L. Walker, 1988 .

Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.

R. Fox, S. Morgan, J. Baggott, 2003, Rheumatology.